+1 213-510-3499 sales@vparesearch.com
+1 213-510-3499 sales@vparesearch.com
Home/ Healthcare
Industry Coverage

Healthcare Market Research & Reports

Healthcare is being revolutionized by telemedicine, AI‑assisted diagnostics, precision therapeutics, and value‑based care models. VPA Research provides exhaustive analyses of pharmaceutical pipelines, medical device innovation, digital health platforms, and hospital service trends. We track regulatory pathways (FDA, EMA), reimbursement shifts, and patient engagement strategies impacting adoption rates. With granular forecasts by therapy area, device type, and delivery model, our insights support life sciences companies, providers, payers, and investors in navigating a complex, patient‑centric healthcare landscape.

Latest Reports in Healthcare

Explore syndicated research, market outlooks, and sector-specific analysis curated for strategy and growth teams.

2457 reports available

Anti-Vascular Endothelial Growth Factor (VEGF) Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Eylea , Lucentis , Avastin , Beovu , Vabysmo , Biosimilars), By Application (Ophthalmology , Oncology ), By Route of Administration (Intravitreal Injection , Intravenous Infusion ), By End User (Hospitals, Specialty Eye Clinics, Ambulatory Surgical Centers) Companies, and Country Forecast, 2021 to 2034

Global Anti-Vascular Endothelial Growth Factor (VEGF) Therapeutics Market size is forecast to increase from $25.86 Billion in 2026 to $38.79 Billion in 2034 at a CAGR of 5.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005687
Pages: 212 Pages

Anti-Tumor Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Cytotoxic Drugs , Targeted Drugs , Hormonal Drugs , Immunotherapy Drugs ), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormone Therapy), By Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancers ), By Route of Administration (Oral, Injectable ), By End User (Hospitals, Specialty Oncology Clinics, Cancer Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Anti-Tumor Drugs Market size is forecast to increase from $303.58 Billion in 2026 to $679.7 Billion in 2034 at a CAGR of 10.6% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005686
Pages: 218 Pages

Anti-tuberculosis Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Disease Type (Active Tuberculosis, Latent Tuberculosis), By Therapy (First-Line TB Drugs, Second-Line TB Drugs, Regimens for Drug-Resistant TB ), By Dosage Form (Oral Tablets & Capsules, Fixed-Dose Combinations , Injectable Formulations), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacies, Retail & Community Pharmacies, Public Procurement Channels, NGOs, & DOTS Programs) Companies, and Country Forecast, 2021 to 2034

Global Anti-tuberculosis Therapeutics Market size is forecast to increase from $2.42 Billion in 2026 to $3.69 Billion in 2034 at a CAGR of 5.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005685
Pages: 212 Pages

Antithrombotic Drugs Market Size, Share and Growth Outlook, 2026: Analysis By Drug Class (Anticoagulants, Antiplatelet Drugs, Thrombolytic Drugs), By Indication (Stroke Prevention and Management, Deep Vein Thrombosis , Pulmonary Embolism , Atrial Fibrillation, Acute Coronary Syndrome ), By Route of Administration (Oral, Parenteral ), By End-User (Hospitals & Clinics, Specialty Cardiovascular Centers, Homecare Settings) Companies, and Country Forecast, 2021 to 2034

Global Antithrombotic Drugs Market size is forecast to increase from $57.55 Billion in 2026 to $104.18 Billion in 2034 at a CAGR of 7.7% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005684
Pages: 212 Pages

Antithrombin Market Size, Share and Growth Outlook, 2026: Analysis By Source Type (Plasma-Derived Antithrombin, Recombinant Antithrombin), By Application (Therapeutics, Research and Diagnostics), By Target Indication (Hereditary Antithrombin Deficiency, Acquired Antithrombin Deficiency , Surgical Support & Extracorporeal Membrane Oxygenation , Hepatic Disorders & Liver Diseases), By Dosage Form (Lyophilized Powder, Liquid Formulation), By End-User (Hospitals and Clinics, Diagnostic Laboratories, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antithrombin Market size is forecast to increase from $832.97 Million in 2026 to $1212.05 Million in 2034 at a CAGR of 4.8% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005683
Pages: 227 Pages

Anti-Thrombin III Testing Market Size, Share and Growth Outlook, 2026: Analysis By Test (Functional Activity Assays , Immunological , Genetic Testing ), By Product Category (Assay Kits and Reagents, Automated Coagulation Analyzers & Systems, Point-of-Care ), By Indication (Hereditary Antithrombin Deficiency Risk Assessment, Acquired Antithrombin Deficiency, Deep Vein Thrombosis , Heparin Resistance Monitoring), By End-User (Hospitals and Coagulation Laboratories, Diagnostic Centers and Pathology Labs, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Anti-Thrombin III Testing Market size is forecast to increase from $405.01 Million in 2026 to $571.57 Million in 2034 at a CAGR of 4.4% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005682
Pages: 210 Pages

Anti-snoring Devices Market Size, Share and Growth Outlook, 2026: Analysis By Device Type (Mandibular Advancement Devices , Tongue-Retaining , Nasal Devices , Position Control Devices, Chin Straps, Expiratory Positive Airway Pressure ), By Patient Age Group (Adult , Pediatric), By Distribution Channel (Brick-and-Mortar Retail , E-Commerce , Direct-to-Consumer ), By End-User (Home Care Settings, Hospitals and Clinics, Sleep Centers) Companies, and Country Forecast, 2021 to 2034

Global Anti-snoring Devices Market size is forecast to increase from $1123.55 Million in 2026 to $2346.09 Million in 2034 at a CAGR of 9.64% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005681
Pages: 214 Pages

Anti-snoring Devices and Snoring Surgery Market Size, Share and Growth Outlook, 2026: Analysis By Product Type (Oral Appliances , Nasal Devices , Position Control Devices & Smart Pillows, Chin Straps, Expiratory Positive Airway Pressure , Continuous Positive Airway Pressure ), By Surgical Procedure (Uvulopalatopharyngoplasty , Laser-Assisted Uvulopalatoplasty , Radiofrequency Ablation , Palatal Stiffening Procedures & Injection Snoreplasty, Pillar Procedure , Maxillomandibular Advancement ), By Gender Target (Male, Female), By End-User (Home Care Settings, Hospitals and Surgical Centers, Sleep Clinics and Diagnostic Centers) Companies, and Country Forecast, 2021 to 2034

Global Anti-snoring Devices and Snoring Surgery Market size is forecast to increase from $2.03 Billion in 2026 to $3.54 Billion in 2034 at a CAGR of 7.2% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005680
Pages: 222 Pages

Antiseptic and Disinfectant Market Size, Share and Growth Outlook, 2026: Analysis By Product (Quaternary Ammonium Compounds, Alcohols and Aldehydes, Chlorine Compounds, Biguanides and Iodine Derivatives, Phenolics, Enzymatic Formulations), By Type of Formulation (Liquids, Sprays and Aerosols, Wipes and Sponges, Gels and Foams), By Application (Surface Disinfectants, Medical Device/Instrument Disinfectants, Skin and Wound Antiseptics , Oral and Nasal Antiseptics), By End User (Hospitals and Clinics, Ambulatory Surgical Centers , Pharmaceutical and Biotechnology Manufacturing, Diagnostic and Research Laboratories) Companies, and Country Forecast, 2021 to 2034

Global Antiseptic and Disinfectant Market size is forecast to increase from $43.67 Billion in 2026 to $83.87 Billion in 2034 at a CAGR of 8.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005679
Pages: 223 Pages

Antisense and RNAi Therapeutics Market Size, Share and Growth Outlook, 2026: Analysis By Technology (Antisense Oligonucleotides , RNA Interference ), By Route of Administration (Intravenous, Subcutaneous, Intrathecal, Ocular/Intravitreal), By Therapeutic Area (Rare Genetic Disorders, Neurological and Neurodegenerative Diseases, Oncology, Cardiometabolic Diseases, Infectious Diseases, Ocular Diseases), By End User (Hospitals, Specialty Clinics, Academic and Research Institutes) Companies, and Country Forecast, 2021 to 2034

Global Antisense and RNAi Therapeutics Market size is forecast to increase from $7.57 Billion in 2026 to $29.43 Billion in 2034 at a CAGR of 18.5% between 2026 and 2034.

Published: June 2026
Report Code: VPA10005678
Pages: 211 Pages